The Proteomics Shared Resource utilizes state-of-the art mass spectrometry instrumentation to support Fred Hutchinson/University of Washington Cancer Consortium (Consortium) investigators. It is the mission of the resource to provide high quality service in a timely manner for proteomic analyses, including molecular weight determinations of proteins and peptides, protein identification and quantification, and protein modification characterization. This application requests continued support for a resource which continues to fulfill an essential role for research within the Consortium.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-39
Application #
8561980
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-01-01
Budget End
2013-12-31
Support Year
39
Fiscal Year
2013
Total Cost
$476,731
Indirect Cost
$181,848
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Cheng, Guang-Shing; Campbell, Angela P; Xie, Hu et al. (2016) Correlation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 22:925-31
Rufener, Gregory A; Press, Oliver W; Olsen, Philip et al. (2016) Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab. Cancer Immunol Res 4:509-19
Gantt, Soren; Orem, Jackson; Krantz, Elizabeth M et al. (2016) Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants. J Infect Dis 214:36-44
Yu, Jeffrey; Storer, Barry E; Kushekhar, Kushi et al. (2016) Biomarker Panel for Chronic Graft-Versus-Host Disease. J Clin Oncol 34:2583-90
Cohen, Stacey A; Laurino, Mercy; Bowen, Deborah J et al. (2016) Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice. Cancer 122:393-401
Chen, Robert; Gopal, Ajay K; Smith, Scott E et al. (2016) Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma. Blood 128:1562-6
Mather, Cheryl A; Mooney, Sean D; Salipante, Stephen J et al. (2016) CADD score has limited clinical validity for the identification of pathogenic variants in noncoding regions in a hereditary cancer panel. Genet Med 18:1269-1275
Song, Xiaoling; Schenk, Jeannette M; Diep, Pho et al. (2016) Measurement of Circulating Phospholipid Fatty Acids: Association between Relative Weight Percentage and Absolute Concentrations. J Am Coll Nutr 35:647-656
Martin, Paul J; Fan, Wenhong; Storer, Barry E et al. (2016) Replication of associations between genetic polymorphisms and chronic graft-versus-host disease. Blood 128:2450-2456
Markley, John L; Brüschweiler, Rafael; Edison, Arthur S et al. (2016) The future of NMR-based metabolomics. Curr Opin Biotechnol 43:34-40

Showing the most recent 10 out of 1027 publications